Julia German Cortes Research technician in the ''Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT'' group of the Vall d'Hebron Research Institute VHIR, working on the synthesis of polymeric and lipidic nanoparticles for drug delivery to treat different types of cancer and, specifically, against cancer stem cells (CSC). Institutions of which they are part Research technician Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca LinkedIn Twitter Orcid Julia German Cortes LinkedIn Twitter Orcid Institutions of which they are part Research technician Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Research technician in the ''Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT'' group of the Vall d'Hebron Research Institute VHIR, working on the synthesis of polymeric and lipidic nanoparticles for drug delivery to treat different types of cancer and, specifically, against cancer stem cells (CSC).
Graduated in Biomedical Sciences in 2021 from the Autonomous University of Barcelona (UAB) with an internship in the UAB group "Human host defense RNases". Master in Translational Biomedical Research from the Vall d'Hebron Research Institute (VHIR) in 2021-2022 which allowed me to do an internship in the Drug Delivery and Targeting (DDT) group of the VHIR working with gelatin nanoparticles for the treatment of cancer of ovary.
Projects SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.. IP: - Collaborators: Marc Miquel Moltó Abad, Olga Sánchez- Maroto Carrizo, Julia German Cortes, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Belen Garcia Prats, Angels Alcina Mila, Maria Fidel Lledò, Fernanda Raquel Da Silva Andrade, Diana Fernandes de Rafael, Simon Schwartz Navarro Funding agency: EUROPEAN COMMISSION Funding: 649580 Reference: SAFE-N-MEDTECHEC_H2020-NMBP2018 Duration: 01/04/2019 - 30/09/2023 Pagination First page « Previous page ‹ Page 1 Current page 2
